a16z Capital Management, L.L.C.

Institutional investor · Portfolio as of Q2 2025

Q2 2025 biggest moves

Reported value$701M → $313M

  • DASHDASH

    DoorDash

    Sold out

    was 42% of portfolio

  • IOTIOT

    Samsara

    Sold out

    was 22% of portfolio

  • OMDAOMDA

    Omada Health

    New listing

    27% of portfolio

5 changes in all

Top Holdings10 positions

Checking export access…
Activity:
RVMD

Revolution Medicines, Inc.

2.7M$101.1M32.3%$28.68+28.28%
7 qtrssince 2023-Q4
Unchanged
0
OMDA

Omada Health, Inc.

4.6M$84.4M27.0%$18.300.00%
1 qtr
New
Unranked
XYZ

Block, Inc.

1M$69.1M22.1%——
7 qtrssince 2023-Q4
Unchanged
0
MAZE

Maze Therapeutics, Inc.

1.7M$20.9M6.7%$11.01+11.44%
2 qtrssince 2025-Q1
Unchanged
0
BIOA

BioAge Labs, Inc.

3.2M$13.4M4.3%$19.78-79.12%
4 qtrssince 2024-Q3
Unchanged
0
NAUT

Nautilus Biotechnology, Inc.

17.7M$12.8M4.1%$2.99-75.75%
7 qtrssince 2023-Q4
Unchanged
0
ERAS

Erasca, Inc.

2.9M$3.6M1.2%$2.13-40.38%
7 qtrssince 2023-Q4
Unchanged
0
OPEN

Opendoor Technologies Inc

6.2M$3.3M1.1%$4.48+77.90%
7 qtrssince 2023-Q4
Unchanged
0
CAMP

CAMP4 Therapeutics Corporation

2.1M$3.1M1.0%$5.22-72.22%
3 qtrssince 2024-Q4
Unchanged
0
DNA

Ginkgo Bioworks Holdings, Inc.

108,568$1.2M0.4%$8.15+38.04%
4 qtrssince 2024-Q3
Unchanged
0
$312.9M
AUM
10
Positions
Q2 2025
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2024-Q1$1,382,426,674-14.9055215448%
2024-Q2$1,172,292,647-15.2003741647%
2024-Q3$1,137,790,470-2.94313685992%
2024-Q4$745,255,646-34.4997461615%
2025-Q1$700,872,513-5.95542391906%
2025-Q2$312,909,254-55.3543264722%
Activity profile
$ moved · Q2'25
New15%Increased0%Decreased0%Exited85%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q10%1-4Q20%1-2Y50%2Y+20%

a16z Capital Management, L.L.C. manages $312.9M across 10 positions as of Q2 2025. Top holdings: RVMD (32.3%), OMDA (27.0%), XYZ (22.1%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2.5/5.0.

Top holdings by portfolio weight

Total AUM$313M
RVMD32.32%
OMDA26.99%
XYZ22.07%
MAZE6.67%
BIOA4.27%
NAUT4.09%
ERAS1.16%
OPEN1.06%
CAMP0.98%
DNA0.39%

Portfolio allocation by GICS sector

Sectors3
Healthcare76.87%
Technology22.07%
Real Estate1.06%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L38
Conviction63
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used